Page last updated: 2024-08-23

pirfenidone and Primary Myelofibrosis

pirfenidone has been researched along with Primary Myelofibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Call, TG; Elliott, MA; Gray, LA; Hoagland, HC; Hook, CC; Li, CY; Margolin, S; Mesa, RA; Schroeder, GS; Tefferi, A; Yoon, SY	1

Trials

1 trial(s) available for pirfenidone and Primary Myelofibrosis

Article	Year
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia. British journal of haematology, 2001, Volume: 114, Issue:1 Topics: Administration, Oral; Adult; Aged; Antifibrinolytic Agents; Bone Marrow; Disease Progression; Female; Humans; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Pyridones; Treatment Failure	2001

Article

Year

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

British journal of haematology, 2001, Volume: 114, Issue:1

Topics: Administration, Oral; Adult; Aged; Antifibrinolytic Agents; Bone Marrow; Disease Progression; Female; Humans; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Pyridones; Treatment Failure

2001